Mizan’s current research focuses on developing Lymph Node and Lung Organ-on-Chip models to study immune responses in various disease contexts, with the goal of enabling novel therapeutic discoveries.
Before joining the Wyss Institute at Harvard, Mizan built a strong foundation in immunology, pulmonary research, autoimmune disorders, and infectious diseases through diverse academic and research experiences. He studid Bachelor and Master in Microbiology from the University of Chittagong, Bangladesh, followed by a Master in Biotechnology from the Royal Institute of Technology (KTH), Sweden, and studied Master in Molecular Life Science, Stockholm Univeristy, Sweden.
He completed his PhD in Immunology at the Karolinska Institute, Sweden, where he investigated natural antibody regulation and T cell activation through both antigen-presenting cell-dependent and independent pathways in atherosclerosis. As a postdoctoral researcher at Karolinska Institute, Mizan studied lipid homeostasis-driven inflammation in the lungs in response to environmental pollutants and viral infections. He also led projects unraveling the role of PCSK9 in arthritis, systemic lupus erythematosus, and lung diseases. Additionally, he collaborated with startup companies, contributing to the application of plasma technology against microorganisms and research on tumor-associated macrophages.
At Brigham and Women’s Hospital, Harvard Medical School, his postdoctoral research focused on the role of the DNA damage repair gene MUTYH in airway diseases and a separate project on p53-mediated, sex-specific mucin regulation. His collaborative efforts have also included research on fibrosis and viral infections in chronic allograft lung dysfunction.